Golding Capital Partners has held a final close for its first dedicated secondaries fund on EUR 280m, surpassing its EUR 200m target.
GP plans to acquire a majority stake in the business, according to a competition authority filing
New GP specialising in healthcare has already deployed 65% of the fund's target
Decision made to halt an initial public offering as a result of volatile market conditions
Sweden-based technology investor has been listed on the Swedish stock exchange since 1997